natgillin/translations-raw huggingface dataset:
In horses, after intravenous injection meloxicam is eliminated with a terminal half-life of 8.5 hours.
U konja po intravenoznom davanju terminalno vrijeme poluraspada je 8.5 sati.
In the case of overdose, symptomatic treatment should be initiated.
U slučaju predoziranja potrebno je provesti simptomatsku terapiju.
2 mg For the full list of excipients, see section 6.1
2 mg Potpuni popis pomoćnih tvari vidi u odjeljku 6.1
Shake bottle well.
Bočicu dobro protresite.
After two intramuscular doses of 0.4 mg meloxicam/kg, a Cmax value of 1.9 μg/ml was reached after 1 hour in pigs.
Nakon dva intramuskularna davanja svinjama u dozi od 0,4 mg meloksikama/kg, Cmax vrijednosti od 1,9 g/ml postignuta je nakon 1 sat.
• Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment.
• Prethodno liječenje s drugim protuupalnim tvarima može rezultirati dodatnim ili pojačanim neželjenim popratnim pojavama te takvo liječenje treba prekinuti najmanje 24 sata prije liječenja Meloxidylom.
Bovine 20 μg/kg 65 μg/kg
Goveda 20 μg/kg 65 μg/kg
Overdose (symptoms, emergengy procedures, antidotes):
Predoziranje (simptomi, hitni postupci, antidot)
Dosing procedure using the measuring syringe:
Način doziranja uz korištenje priložene graduirane brizgalice:
• Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
• Pri istovremenoj primjeni s drugim NSPUL, diureticima, antikoagulansima, aminoglikozidnim antibioticima i tvarima koje se u visokom postotku vežu na proteine, može zbog kompetitivnog učinka doći do toksičnog djelovanja.
More than 98 % of meloxicam is bound to plasma proteins.
Više od 98 % meloksikama veže se na proteine plazme.
The suspension can be given using the measuring syringe provided in the package.
Suspenzija se može dati graduiranom brizgalicom priloženom u pakovanju.
Return the bottle and syringe upright and remove the syringe.
Vratite spojenu bočicu i brizgalicu u prvobitni položaj te brizgalicu te ih razdvojite.
Meloxidyl 20 mg/ml:
Za Meloxidyl 20 mg/ml:
After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmaxvalues of 2.1 μg/ml and 2.7 μg/ml were reached after 7.7 hours and 4 hours in young cattle and lactating cows, respectively.
Nakon jednog subkutanog davanja doze od 0,5 mg meloksikama/kg, Cmax vrijednosti od 2,1 μg/ml i 2,7 μg/ml postignute su nakon 7.7 sati u junadi odnosno 4 sata u krava u laktaciji.
Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.
Umanjenje post operativnih bolova nakon ovariohisterektomije i manjih operacija mekih tkiva.
Route and method of administration
Način i put primjene
2.0 mg For the full list of excipients, see section 6.1
2,0 mg Potpuni popis pomoćnih tvari vidi u odjeljku 6.1
Cattle: meat and offal: 15 days; milk: 5 days Pigs: meat and offal: 5 days Horses: meat and offal: 5 days
Goveda: Meso i iznutrice: 15 dana; Mlijeko: 5 dana Svinje: Meso i iznutrice: 5 dana Konji: Meso i iznutrice: 5 dana
Approximately 50 % of the administered dose is eliminated via urine and the remainder via faeces.
Oko 50 % unesene doze eliminira se putem mokraće, a ostatak preko izmeta.
Pharmacologically active substance(s)
Farmakološki djelatna(e) tvar(i)
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Ne koristiti u slučajevima preosjetljivosti na djelatnu tvar ili neku od pomoćnih tvari.
Overdose (symptoms, emergency procedures, antidotes): In the case of overdose, symptomatic treatment should be initiated.
Predoziranje (simptomi, hitni postupci, antidoti): U slučaju predoziranja potrebno je provesti simptomatsku terapiju.
In dogs, these side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
U pasa, ove se pojave uglavnom javljaju u prvom tjednu liječenja, većinom su prolazne naravi te se spontano povuku po prestanku terapije.
EXP: Once opened use within 6 months.
ROK VALJANOSTI EXP: {mjesec/godina} Jednom otvoren upotrijebiti do 6 mjeseci
Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Ublažavanje blažih do umjerenih post operativnih bolova i upala nakon kirurških zahvata u mačaka (npr. ortopedske operacije i operacije mekih tkiva).
Dogs: intravenous or subcutaneous use Cats: subcutaneous use
NAČIN I PUT(EVI) PRIMJENE Psi: za intravenozno ili subkutano davanje Mačke: za subkutano davanje
Cattle, pigs, horses
CILJNE VRSTE ŽIVOTINJA Govedo, svinja, konj.
There is a linear relationship between the dose administered and plasma concentration observed in the therapeutic dose range in dogs.
Uočljiv je linearni odnos između primijenjene doze i koncentracije u plazmi pri davanju u veterinarsko-medicinskog proizvoda u terapijskim dozama.
The syringe fits onto the bottle and has a kg-body weight scale (from 1 kg to 10 kg) which corresponds to the maintenance dose.
Brizgalica odgovara otvoru na boci, a naznačena gradacija (od 1 do 10 kg) odgovara dozi održavanja.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment.
Prethodno liječenje s drugim protuupalnim tvarima može rezultirati dodatnim ili pojačanim neželjenim popratnim pojavama te takvo liječenje treba prekinuti najmanje 24 sata prije liječenja Meloxidylom.
When the product is used according to the recommended dosage regime, steady state concentrations of meloxicam in plasma are reached on the second day of treatment.
Kada se veterinarsko-medicinski proizvod koristi u propisanim količinama, ustaljenost koncentracije u plazmi postiže se drugog dana liječenja.
Approximately 75 % of the administered dose is eliminated via faeces and the remainder via urine.
Oko 75% aplicirane doze eliminira se putem izmeta dok se ostatak izlučuje mokraćom.
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
Za smanjenje simptoma šepavosti i upale pri neinfektivnim lokomotornim poremećajima.
Meloxicam is eliminated with a half-life of 24 hours.
Poluvrijeme eliminacije meloksikama iz organizma je 24 sata.
PHARMACOLOGICAL PROPERTIES
FARMAKODINAMIČKA SVOJSTVA
In horses, a transient swelling at the injection site can occur but resolves without intervention.
U konja se na mjestu davanja može javiti manja prolazna oteklina koja se spontano povuče bez liječenja.
PACKAGE LEAFLET: Meloxidyl 1.5 mg/ml oral suspension for dogs 10, 32 & 100 ml
UPUTA O VMP Meloxidyl 1,5 mg/ml peroralna suspenzija za pse 10 ml, 32 ml i 100 ml
Meloxicam 20 mg
Meloksikam 20 mg
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Pri istovremenoj primjeni s drugim NSPUL, diureticima, antikoagulansima, aminoglikozidnim antibioticima i tvarima koje se u visokom postotku vežu na proteine, može zbog kompetitivnog učinka doći do toksičnog djelovanja.
Muscle Liver Kidney Milk
Meso Mišići Jetra Bubrezi
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e)) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na10.000 tretiranih životinja) - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.
Za ublažavanje kliničkih znakova pri akutnim respiratornim infekcijama, uz odgovarajuću antibiotsku terapiju.
Meloxicam Meloxicam
Meloksikam Meloksikam
Solution for injection.
OBLIK Injekcijska otopina.
Dogs: IV or SC Cats: SC
PUT(EVI) PRIMJENE Psi: i.v. ili s.c.
Approximately 97 % of meloxicam is bound to plasma proteins.
Oko 97 % meloksikama veže se uz proteine plazme.
More than 97 % of meloxicam is bound to plasma proteins.
Više od 97 % meloksikama veže se uz proteine plazme.
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Ne koristiti istovremeno s glukokortikosteroidima, drugim NSPUL ili s antikoagulansima.
In cattle, meloxicam is also a major excretion product in milk and bile whereas urine contains only traces of the parent compound.
U goveda, meloksikam se većinom izlučuje kroz mlijeko i žuć dok se u mokraći nalazi samo u tragovima.
A clinical response is normally seen within 7 days.
Klinički učinak uočljiv je unutar 7 dana od početka liječenja.
- Do not use in cats less than 6 weeks of age.
Ne koristiti u mačaka mlađih od 6 tjedana.
In case of overdose, adverse reactions, as listed in Section 4.6, are expected to be more severe and more frequent.
U slučaju predoziranja popratne reakcije opisane u dijelu 4.6 znatno su izraženije i učestalije te je potrebno primijeniti simptomatsku terapiju.
Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Ne koristiti u životinja s gastrointestinalnim poremećajima, kao što su iritacije i krvarenja, smanjenom funkcijom jetre, srca ili bubrega te hemoragijskim poremećajima.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
S neiskorištenim veterinarsko - medicinskim proizvodom i praznom ambalažom postupa se u skladu s lokalnim propisima.
Meloxidyl must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Meloxydil se ne smije primjenjivati istodobno s drugim NSPUL ili glukokortikosteroidima.
Post-operative pain and inflammation following surgical procedures: After initial treatment with meloxicam 2 mg/ml solution for injection for cats, continue treatment 24 hours later with Meloxidyl 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg bodyweight.
Nakon početnog jednokratnog parenteralnog davanja meloksikama 2 mg/ml injekcijske otopine za mačke, liječenje se nastavlja nakon 24 sata davanjem Meloxidyl 0,5 mg/ml peroralne suspenzije za mačke u dozi od 0,05 mg meloksikama/kg tjelesne mase.
A clinical response is normally seen within 3 - 4 days.
Klinički učinak uočljiv je 3 - 4 dana od početka liječenja.
Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by E. coli endotoxin administration in calves, lactating cows and pigs.
Meloksikam ima i anti - endotoksična svojstva jer se pokazalo da inhibira stvaranje tromboksana B2 izazvano unosom endotksina E.
One ml contains:
SASTAV DJELATNIH TVARI 1 ml sadržava:
EXP:
ROK VALJANOSTI EXP:
Veterinary medicinal product subject to prescription.
Veterinarsko-medicinski proizvod je potrebno pažljivo dozirati.
For the relief of post-operative pain following dehorning in calves.
Za ublažavanje postoperacijskih bolova nakon odrožnjavanja teladi.
Attach the dosing syringe to the bottle by gently pushing the end onto the top of the bottle.
Namjestite brizgalicu na otvor bočice uz lagani pritisak
Oral use.
Za peroralno davanje.
Cardboard box containing 5 ml glass bottle with one measuring syringe.
Kartonska kutija sa staklenom bočicom od 5 ml te jednom graduiranom brizgalicom.
In cattle and pigs, subcutaneous, intramuscular as well as intravenous administration is well tolerated; only a slight transient swelling at the injection site following subcutaneous administration was observed in less than 10 % of the cattle treated in clinical studies.
U kliničkim pokusima, manja prolazna oteklina na mjestu uboda pri subkutanom davanju primijećena je u manje od 10 % liječenih goveda.
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Ukoliko se jave nuspojave, liječenje treba prekinuti i potražiti savjet veterinara.
EXP Once opened, use within 6 months.
Jednom otvoren upotrijebiti do 6 mjeseci.
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non steroids.
Farmakoterapijska grupa: nesteroidni protuupalni i antireumatski pripravci.
Reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery.
Ublažavanje post operativnih bolova i upala nakon ortopedskih kirurških zahvata i operacija mekih tkiva).
Silica colloidal anhydrous Sorbitol liquid non-crystallising Glycerol, xylitol Sodium benzoate Citric acid anhydrous Purified water.
Ksantanska guma Silicijev dioksid koloidni bezvodni Sorbitol, tekući nekristalizirajući Glicerol
Do not use in dogs less than 6 weeks of age.
Ne koristiti u pasa mlađih od 6 tjedana.
32 ml bottle in a cardboard box
Bočice od 32 ml u kartonskoj kutiji
PACKAGE LEAFLET: Meloxidyl 20 mg/ml solution for injection for cattle, pigs, horses 50, 100, & 250 ml
UPUTA O VMP Meloxidyl 20 mg/ml, injekcijska otopina za goveda svinje i konje 50 ml, 100 ml i 250 ml
10 ml bottle in a cardboard box
Bočice od 10 ml u kartonskoj kutiji
The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e)) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na10.000 tretiranih životinja)
Cardboard box containing 15 ml high density polyethylene bottle with one measuring syringe.
Kartonska kutija s bočicom od polietilena visoke gustoće od 15 ml te jednom graduiranom brizgalicom.
Meloxicam 5 mg/ml Excipients: Ethanol 150 mg/ml
Meloksikam 5 mg/ml Pomoćna tvar: Etanol 150 mg/ml
Following subcutaneous administration, meloxicam is completely bioavailable and maximal mean plasma concentrations of 0.73 μg/ml in dogs and 1.1 μg/ml in cats were reached approximately 2.5 hours and 1.5 hours post administration, respectively.
Po subkutanom davanju meloksikam je u cijelosti bioraspoloživ te prosječno kod pasa za približno 2.5 sata postiže vršnu koncentraciju u plazmi od 0,73 μg/ml, dok kod mačaka za približno 1.5 sat postiže vršnu koncentraciju od 1,1 μg/ml.
Shelf life after first opening the container: 6 months.
Rok valjanosti poslije prvog otvaranja spremnika: 6 mjeseci.
Meloxidyl 1.5 mg/ml - Meloxidyl 5 mg/ml - Meloxidyl 0.5 mg/ml Not applicable
Za Meloxidyl 1,5 mg/ml, Meloxidyl 5 mg/ml, Meloxidyl 0,5 mg/ml:
Method and route of administration
Načini i put primjene
Ethanol, anhydrous Poloxamer 188
Poloksamer 188
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box of 10 ml vial
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Kartonska kutija za bočicu od 10 ml
Solution for injection Clear, colourless to yellowish solution.
Bistra, bezbojna do žućkasta otopina.
Meloxidyl 1.5 mg/ml oral suspension may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of the injection.
U nastavku liječenja može se koristiti Meloxidyl 1,5 mg/ml peroralna suspenzija u dozi od 0,1 mg meloksikama/kg tjelesne mase, 24 sata nakon davanja injekcije.
PARTICULARS TO APPEAR ON THE OUTER PACKAGE Cardboard box of 15 ml vial
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU Kartonska kutija za bočicu od 15 ml
Turn the bottle and syringe upside down.
Okrenite spojenu bočicu brizgalicu.
100 ml bottle in a cardboard box
Bočice od 100 ml u kartonskoj kutiji
Concurrent administration of potential nephrotoxic drugs should be avoided.
Potrebno je izbjegavati istodobnu primjenu s drugim potencijalno nefrotoksičnim veterinarsko-medicinskim proizvodima.
One ml contains: Meloxicam
1 ml sadržava: Meloksikam
Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg body weight (i.e. 0.06 ml/kg body weight) before surgery, for example at the time of induction of anaesthesia.
Jednokratno subkutano davanje u dozi od 0,3 mg meloksikama/kg tjelesne mase (odnosno 0,06 ml/kg tjelesne mase) prije kirurškog zahvata, primjerice pri uvođenju u anesteziju.
These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
One se uglavnom javljaju u prvom tjednu liječenja, većinom su prolazne naravi te se spontano povuku po prestanku terapije.
Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent.
Ukoliko se kliničko stanje ne popravi, liječenje treba prekinuti najkasnije za 14 dana.
• If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.
• Ukoliko se primijete nuspojave, liječenje treba prekinuti i potražiti savjet veterinara.
Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e. 0.4 ml/10 kg body weight) before surgery, for example at the time of induction of anaesthesia.
Jednokratno intravenozno ili subkutano davanje u dozi od 0,2 mg meloksikama/kg tjelesne mase (odnosno 0,4 ml/10 kg tjelesne mase) prije kirurškog zahvata, primjerice pri uvođenju u anesteziju.
Musculo-skeletal disorders:
Mišićno - koštani poremećaji:
Name and address of the manufacturers responsible for batch release
Naziv i adresa proizvođača odgovornog(ih) za puštanje serije u promet:
Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
Ukoliko se kliničko stanje ne popravi, liječenje treba prekinuti najkasnije za 10 dana.
Excipients
NUSPOJAVE
• People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product.
• Osobe preosjetljive na nesteroidne protuupalne NSPUL trebaju izbjegavati kontakt s ovim veterinarsko - medicinskim proizvodom.
The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose (i.e. 0.1 mg meloxicam/kg body weight).
Brizgalica odgovara otvoru na boci, a naznačena gradacija odgovara dozi održavanja (tj. 0,1 mg/meloksikama /kg tjelesne mase).
Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.
Nastavlja se dnevnim (u razmacima od 24 sata) peroralnim davanjem održavajuće doze od 0,1 mg meloksikama/kg tjelesne mase.
Label of 250 ml vial
Etiketa bočice od 250 ml
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Label of 100 ml vial
PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKOVANJU Etiketa bočice od 100 ml
Do not use this veterinary medicinal product after the expiry date which is stated on the carton and the bottle after EXP.
Ne koristite veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na kartonskoj kutiji i bočici poslije EXP.
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
Jednokratno subkutano ili intravenozno davanje u dozi od 0,5 mg meloksikama/kg tjelesne mase (tj. 2,5 ml/100 kg tjelesne mase), po potrebi u kombinaciji s antibiotskim liječenjem ili peroralnom rehidracijom.
Cardboard box of 5 ml vial
Kartonska kutija za bočicu od 5 ml
Special precautions for storage
Posebne mjere opreza pri čuvanju
Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.05 mg meloxicam/kg body weight.
Nastavlja se dnevnim (u razmacima od 24 sata) peroralnim davanjem održavajuće doze od 0,05 mg meloksikama/kg tjelesne mase.
PACKAGE LEAFLET: Meloxidyl 0.5 mg/ml oral suspension for cats 15 & 5 ml
UPUTA O VMP Meloxidyl 0,5 mg/ml peroralna otopina za mačke 15 ml i 5 ml
Meloxidyl 20 mg/ml solution for injection for cattle, pigs and horses
Meloxidyl 20 mg/ml, injekcijska otopina za goveda, svinje i konje.
Solution for injection
OBLIK Injekcijska otopina
Meloxidyl 1.5 mg/ml oral suspension for dogs.
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA Meloxidyl 1,5 mg/ml peroralna suspenzija za pse.
People with known hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product.
Osobe preosjetljive na nesteroidne protuupalne lijekove (NSPUL) trebaju izbjegavati kontakt s ovim veterinarsko - medicinskim proizvodom.
These side effects are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Vrlo rijetko ove nuspojave mogu biti ozbiljne naravi ili fatalne.
Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day.
Liječenje započinje jednokratnom dozom od 0,2 mg meloksikama/kg tjelesne mase prvog dana.
The product must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Ovaj veterinarsko-medicinski proizvod ne smije se primjenjivati istodobno s drugim NSPUL ili glukokortikosteroidima.
Meloxidyl 1.5 mg/ml oral suspension for dogs may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of the injection.
U nastavku liječenja može se koristiti Meloxidyl 1,5 mg /ml peroralna suspenzija za pse u dozi od mg meloksikama/kg tjelesne mase, 24 sata po davanju injekcije.
Push down and unscrew bottle top.
Čep prije odvrtanja pritisnite prema dolje.
Cardboard box of 32 ml vial
Kartonska kutija za bočicu od 32 ml
Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams) ATC-vet code: QM01AC06
Farmakoterapijska grupa: nesteroidni protuupalni i antireumatski veterinarsko-medicinski proizvodi (oksikami).
Meloxidyl 0.5 mg/ml
Meloksikam 0,5 mg
To be administered mixed with food.
Veterinarsko-medicinski proizvod se daje se umiješan u hrani.
Cats: single administration of 0.3 mg meloxicam/kg body weight (i.e. 0.06 ml/kg).
Mačke: jednokratno davanje 0,3 mg meloksikama/kg tjelesne mase (tj. 0,06 ml/kg).
Z.I.
A.
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e. 0.4 ml/10 kg body weight).
Jednokratno subkutano davanje u dozi od 0,2 mg meloksikama/kg tjelesne mase (odnosno 0,4 ml/10 kg tjelesne mase).
Initial treatment is a single oral dose of 0.1 mg meloxicam/kg body weight on the first day.
Liječenje započinje jednokratnom dozom od 0.1 mg meloksikama/kg tjelesne mase prvog dana.
Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e. 3.0 ml/100 kg body weight).
Jednokratno intravensko davanje u dozi od 0,6 mg meloksikama/kg tjelesne mase (tj. 3,0 ml/100 kg tjelesne mase).
Cardboard box of 100 ml vial
Kartonska kutija za bočicu od 100 ml
PACKAGE LEAFLET: Meloxidyl 5 mg/ml solution for injection for dogs, cats 10 ml
UPUTA O VMP Meloxidyl 5 mg/ml, injekcijska otopina za pse i mačke 10 ml
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 2.0 ml/100 kg body weight) in combination with antibiotic therapy, as appropriate.
Jednokratno intramuskularno davanje u dozi od 0,4 mg meloksikama/kg tjelesne mase (tj. 2,0 ml/ 100 kg tjelesne mase u kombinaciji s odgovarajućim antibiotskim liječenjem.